Please provide your email address to receive an email when new articles are posted on . VTx-002 targets proteins that play a significant role in neurodegenerative disease. Enrollment in and ...

VectorY Therapeutics Receives FDA Fast Track Designation for VTx-002, a First-in-Class Vectorized Antibody Targeting Underlying Disease Biology in ALS ~ Designation enables an enhanced development ...

(NEXSTAR) – In 2025, nearly 300,000 Americans used a new electronic system to file their taxes directly with the IRS for free. In 2026, that’s no longer an option. IRS Direct File launched as a pilot ...

AMSTERDAM & BOSTON--(BUSINESS WIRE)--VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) ...

VectorY Therapeutics has seen the shape of things to come—and it involves finding fresh ways to deliver its gene therapies into the brain. The Dutch biotech has secured an exclusive option to evaluate ...

AMSTERDAM & BOSTON & SEATTLE--(BUSINESS WIRE)--VectorY Therapeutics, a biotechnology company developing innovative vectorized antibody therapies for the treatment of neurodegenerative diseases, and ...

With social media at play, there is a strong level of pressure now more than ever to fit certain beauty standards and body types. Luckily, there are women who are also on social media who own their ...

AI is at a crossroads. Enterprises have spent the last several years exploring AI technologies, but most are still searching for revenue-generating opportunities. This year, I expect business AI to ...

IRS Supervisory Special Agent Gary Shapley, whose whistleblower testimony was pivotal to House Republicans’ corruption investigation into Hunter Biden, was named the agency’s next acting commissioner.

President Donald Trump is set to name Gary Shapley, the former IRS criminal investigator who alleged that the Justice Department slow-walked the investigation of Hunter Biden, as acting commissioner ...